Related Experiment Video

Updated: Feb 26, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K

Fecal Microbial Transplantation in Inflammatory Bowel Disease: A Movement Too Big to Be Ignored

M Laffin1,2, K L Madsen2,3

  • 1Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

Clinical Pharmacology and Therapeutics
|July 12, 2017
PubMed

Insights

Fecal microbial transplants show promise for treating inflammatory bowel disease (IBD), offering an alternative to traditional drugs. Further research is needed to confirm long-term safety and optimal stool composition for effective disease management.

Area of Science:

  • Gastroenterology
  • Microbiome Research
  • Immunology

Background:

  • Developing novel therapies for inflammatory bowel disease (IBD) faces challenges including high costs, adverse effects, and inconsistent efficacy.
  • Pharmacologic treatments for IBD often have limitations, necessitating exploration of alternative therapeutic strategies.

Purpose of the Study:

  • To evaluate fecal microbial transplantation (FMT) as a potential alternative therapy for inflammatory bowel diseases.
  • To assess the efficacy of FMT in inducing disease remission in patients with IBD.

Main Methods:

  • Review of randomized controlled trials investigating fecal microbial transplantation for inflammatory bowel diseases.
  • Analysis of data on disease remission rates following FMT.

Main Results:

  • Fecal microbial transplantation has demonstrated the ability to induce disease remission in randomized controlled trials for IBD.
  • FMT presents a viable alternative to conventional pharmacologic therapies for IBD.

Conclusions:

  • Fecal microbial transplantation is a promising therapeutic option for managing inflammatory bowel diseases.
  • Further investigation is required to determine the long-term safety and optimal stool donor criteria for FMT in IBD treatment.

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
Murine Fecal Isolation and Microbiota Transplantation07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.7K

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
769
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
76.4K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
852
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
604
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K